ClinicalTrials.govpublic full text
A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma
melanoma, tpi 287, microtubule inhibitor, temozolomide, temodar, cytotoxic agent, unresectable stage iii, stage iv, metastatic melanoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 855149
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.